Log In
Print
BCIQ
Print
Print this Print this
 

Innohep, tinzaparin

  Manage Alerts
Collapse Summary General Information
Company Leo Pharma A/S
DescriptionOnce-daily low molecular weight heparin
Molecular Target Factor Xa ; Thrombin (Factor IIa) (F2)
Mechanism of ActionAnti-thrombotic/thrombolytic
Therapeutic ModalityMacromolecule: Polysaccharide
Latest Stage of DevelopmentMarketed
Standard IndicationDeep vein thrombosis (DVT)
Indication DetailsTreat acute symptomatic deep vein thrombosis (DVT)
Regulatory Designation

Partner

Celgene Corp.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today